BOLETÍN HTA

HIPERTENSIÓN / 2018 / VOL. 23 57 Referencias 1. Encuesta Nacional de Salud 2016-2017. www.minsal.cl . 2. Fasce E, Campos I, Ibáñez P. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens 2007; 25:1807-1811. 3. Mueller N, Noya-Alarcon O, Contreras M, et. al. Association of Age With Blood Pressure Across the Lifespan in Isolated Yanomani and Yekwana Villages. JAMA Cardiology 2018; November 14 (online). 4. Bouvet C, Essalihi R, Gilbert L, et al. Arterial Stiffness as a Therapeutic Target For Isolated Systolic Hypertension: Focus on Vascular Calcification and Fibrosis. Current Hyper Rew 2010; 6:20-31. 5. Safar M. Systolic Hypertension in the Elderly: Arterial Wall Mechanical Properties and the Renin-angiotensin-aldosterone System. J Hypertens 2005; 23: 673-681. 6. Wallace SM, Yasmin, McEniery CM, et al. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 2007; 50:228-33. 7. Benetos A, Thomas F, Joly L, et al. Pulse pressure amplification: a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol 2010; 55:1032-1037. 8. Safar M. Mechanism(s) of Systolic Blood Pressure Reduction and Drug Therapy in Hypertension. Hypertension 2007; 50:167-171. 9. Gerhard M, Roddy MA, Creager SI, et al. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996; 27:849-53. 10. Stewart KJ, Sung J, Silber Ha, et al. Exaggerated exercise blood pressure is related to impaired endothelial vasodilator function. Am J Hypertens 2004; 17:314-20. 11. Bryg RJ, Williams GA, Labovitz AJ, et al. Effect of aging on left ventricular diastolic filling in normal subjects. Am J Cardiol 1987; 59:971-4. 12. Messerli FH, Sundgaard-Riise K, Ventura HO, et al. Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 1983 Oct; 2(8357):983-6. 13. Staessen J, Gasowski J, Wang J, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355:865-72. 14. SHEP Cooperative Research Group. Final results of the Systolic Hypertension in the Elderly Program. JAMA 1991; 154:2154-60. 15. Staessen JA, Fagard R, Thijs L, et al. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350:757-64. 16. Liu L, Wang JG, Gong L, et al. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998; 16:1823-29. 17. Yano Y, Rakugi H, Bakris GL, et al. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension. Hypertension 2017;69: 220-27. 18. Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1(8442):1349-54. 19. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986; 293:1145-51. 20. Daholf B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338:1281-5. 21. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304:405-12. 22. PROGRESS Collaborative Study Group. Randomised trial of perindopril based blood pressure-lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-41. 23. JATOS Study Group. Principle results of the Japanesse Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (SATOS). Hypertens Res 2008; 31:2115-24. 24. Zhang Y, Zhang W, Liu L, et al. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. Eur Heart J 2011; 32:1500-8. 25. Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs Standadrd Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged > 75 Years. A Randomized Clinical Trial. JAMA 2016; 315:2673-2682. 26. Beckett N, Peters R, Fletcher A, et al. Treatment of hypertension in patients 80 years of age and older. N Eng J Med 2008; 358:1887-1898. 27.Lonn EM, Bosch J, Jaramillo PL, et. Al. Blood pressure lowering in intermediate-risk persons without cardiovascular disease. N Eng J Med 2016; 374:2009-20. 28. ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017, Nov 13. 29. Fasce E, Zárate LH y Ortiz L. Consideraciones en torno a las Guías USA 2017 de hipertensión arterial. Rev Méd Chile 2018; 146:1317.1324. 30. Angelousi A, Girard N, Benetos A, et al. Association between orthostatic hypotension and cardiovascular risk: a systematic review and meta-analysis. J Hypertens 2014; 32:1562-71. 31. Corrao G, Mazzola P, Monzio M, et al. Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: A population-based cohort study of 81617 Italian patients newly treated between 2005 and 2009. Drugs Aging 2015; 32:927-36. 32. Yap P, Niti M, Yap K, et al. Orthostatic hypotension, hypotension and cognitive status: early comorbid markers of primary dementia. Dement Geriatr Cogn Disord 2008; 26:239-46. 33. Peters R, Anstey K, Booth A, et al. Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment: an integrated evidence: review and analysis of a large older adult hypertensive cohort. Eur Heart J 2018; 39: 3135-43. 34. Chrysant S. Aggressive systolic blood pressure control in older subjects: benefits and risks. Postgraduate Med 2018;130:159-65. 35. Denardo S, Gong Y, Nichols W, et al. Blood pressure and outcomes in very old hypertensives coronary artery disease patients: an INVEST substudy. Am J Med 2010; 123:719-726 36. Bangalore S, Messerli F, Wun C, et al. J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J 2010; 23:2897-908. 37. Vidal-Pierot E, Ford I, Greenlaw N, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet 2016; 388: 2142–52. 38. Poulter N, Castillo R, Charchar F, et al. Are the American Heart Association/American College of Cardiology High Blood Pressure Guideliness Fit for Global Purpose?. Thoughts From the International Society of Hypertension. Hypertension 2018; 72: 260-2. 39. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart J. 25 agosto 2018. https://doi.org/10.1093/eurheartj/ehy339. 40. Stokes G, Bune A, Huon N, et al. Long-Term effectiveness of extended-release nitrate for the treatment of systolic hypertension. Hypertension 2005; 45:380-384.